The Tsinghua-backed DNA and RNA sequencing equipment manufacturer has added $63m to its coffers.
QitanTech, a China-based genomics technology developer backed by Tsinghua University, received RMB400m ($63m) in series B funding yesterday co-led by GL Ventures, the venture capital arm of private equity group Hillhouse Capital.
CDH Venture and Growth Capital, a fund owned by asset manager CDH Investments, co-led the round, which also included internet company Baidu’s investment unit Baidu Ventures and insurance provider Sunshine Insurance Group’s asset management vehicle Riverhead Capital.
Alwin Capital, BioTrack Capital, Gaorong Capital, Huagai Capital, Yinxinggu…
